NASDAQ:SRZN

Surrozen Stock Insider Trading

Healthcare > Biotechnology

Buy SRZN

*Your capital is at risk

$24.57

+1.43 (+6.16%)

At Close: Jun 03, 2026

Surrozen Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 94.09. In total, the insiders bought 2.08M and sold 12.49K SRZN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	94.09
● Buy	2.08M shares
● Sell	12.49K shares
94% Buy Activity Negligible or No Correlation
Sell Signal Low Confidence May 04, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 94.09. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Dec 15, 2025 Buy	Common Stock A-Award	Parker Craig C Chief Executive Officer	CEO / President	1 553 Value: $12.6K
Dec 15, 2025 Buy	Common Stock A-Award	Williams Charles O Chief Operating Officer	C-Suite Officer	1 666 Value: $13.5K
Dec 15, 2025 Buy	Common Stock A-Award	Li Yang Exec. Vice President, Research	CEO / President	1 666 Value: $13.5K
Dec 05, 2025 Buy	Common Stock P-Purchase	Column Group Iii Gp, Lp 10 Percent Owner	10% Owner	14 503 Value: $283.4K
Dec 05, 2025 Buy	Common Stock P-Purchase	Column Group Iii Gp, Lp 10 Percent Owner	10% Owner	16 381 Value: $320.1K
Dec 05, 2025 Buy	Common Stock P-Purchase	Kutzkey Tim	Director	14 503 Value: $283.4K
Dec 05, 2025 Buy	Common Stock P-Purchase	Kutzkey Tim	Director	16 381 Value: $320.1K
Dec 04, 2025 Buy	Common Stock P-Purchase	Column Group Iii Gp, Lp 10 Percent Owner	10% Owner	2 475 Value: $42.9K
Dec 04, 2025 Buy	Common Stock P-Purchase	Column Group Iii Gp, Lp 10 Percent Owner	10% Owner	2 791 Value: $48.4K
Dec 04, 2025 Buy	Common Stock P-Purchase	Kutzkey Tim	Director	2 475 Value: $42.9K
Dec 04, 2025 Buy	Common Stock P-Purchase	Kutzkey Tim	Director	2 791 Value: $48.4K
Nov 13, 2025 Buy	Common Stock P-Purchase	Kutzkey Tim	Director	167 307 Value: $2.12M
Nov 13, 2025 Buy	Common Stock P-Purchase	Kutzkey Tim	Director	148 150 Value: $1.87M
Nov 13, 2025 Buy	Common Stock P-Purchase	Column Group Iii Gp, Lp 10 Percent Owner	10% Owner	167 307 Value: $2.12M
Nov 13, 2025 Buy	Common Stock P-Purchase	Column Group Iii Gp, Lp 10 Percent Owner	10% Owner	148 150 Value: $1.87M
Nov 12, 2025 Buy	Employee Stock Option (right to buy) A-Award	Maleki Andrew Pedrum Chief Financial Officer	C-Suite Officer	50 000 Value: $647.0K
Nov 12, 2025 Buy	Common Stock J-Other	Maleki Andrew Pedrum Insider	Other	0 Value: $0
Jun 13, 2025 Buy	Common Stock A-Award	Li Yang Exec. Vice President, Research	CEO / President	400 Value: $3K
Jun 13, 2025 Buy	Common Stock A-Award	Williams Charles O CFO And COO	C-Suite Officer	400 Value: $3K
Jun 13, 2025 Buy	Common Stock A-Award	Parker Craig C Chief Executive Officer	CEO / President	400 Value: $3K
Jun 13, 2025 Buy	Common Stock A-Award	Parker Craig C Chief Executive Officer	CEO / President	400 Value: $3K
Jun 13, 2025 Buy	Common Stock A-Award	Williams Charles O CFO And COO	C-Suite Officer	400 Value: $3K
Jun 13, 2025 Buy	Common Stock A-Award	Li Yang Exec. Vice President, Research	CEO / President	400 Value: $3K
May 14, 2025 Buy	Option (right to buy) A-Award	Bjerkholt Eric Director	Director	1 333 Value: $9K
May 14, 2025 Buy	Option (right to buy) A-Award	Berkenblit Anna Director	Director	1 333 Value: $9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT SURROZEN, INC.

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 a tissue-specific R-spondin mimetic...

Read Full Profile Here